Endocrine Abstracts

The ideal antiresorptive agent to preserve or further increase bone mineral density (BMD) following teriparatide treatment is not known. We aimed to compare BMD changes after one year of therapy with denosumab or bisphosphonates in osteoporotic patients who had completed treatment with teriparatide. We retrospectively analyzed 140 women (age 74 years, 26 years from menopause, BMI 27 kg/m2 on average) with severe postmenopausal osteoporosis who had been treated betwe...

Introduction: Polycystic ovary syndrome (PCOS) is highly prevalent in women with type 1 diabetes mellitus (T1DM), possibly due to premenarchal exogenous hyperinsulinism (supraphysiological doses and nonphysiologic route of insulin administration). Our aim was to determine if PCOS was related to daily or basal insulin dose or T1DM duration.Methods: We examined 47 women with T1DM (mean age 36.02 years, ±6.03) treated with continuous subcutaneous insul...